Host: John E. Anderson, MD Guest: Michael Greenberg, MD Dr. John Anderson joins Dr. Michael Greenberg, host of DermConsult, to discuss skin diseases that dermatologists should be aware of in patients with diabetes.

Diabetes Discourse

Diabetes & Dermatology: Uncovering Skin Conditions in Diabetic Patients

Host: Carol Wysham, MD Guest: Kristen Nadeau, MD, MS Is there a link between type 2 diabetes and obesity? Dr. Carol Wysham joins Dr. Kristen Nadeau, a Professor of Pediatric Endocrinology at the University of Colorado School of Medicine, to review her research on type 2 diabetes and what it could mean for our patients.

Investigating the Link Between Type 2 Diabetes & Obesity

Guest: Carol Wysham, MD ReachMD host Dr. Carol Wysham discusses what we currently know about hypoglycemia and cardiovascular disease, how to identify patients at risk for severe hypoglycemia, and the strategies and approaches to mitigate risk of hypoglycemia.

A Look at the Link: Exploring the Relationship Between Severe Hypoglycemia & Cardiovascular Risk in Adults with Type 2 Diabetes

Guest: David M. Simpson, MD Guest: Jon T. Gertken, MD Guest: Stephanie Simon, NP Find the full Prescribing Information here. There are multiple ways to incorporate the use of Qutenza, a topical treatment for painful diabetic peripheral neuropathy of the feet, into practice. Tune in to hear Dr. David M. Simpson, Dr. Jon T. Gertken, and Ms. Stephanie Simon share their best practices for administering Qutenza as well as the management of painful diabetic peripheral neuropathy of the feet. QUTENZA® is a registered trademark of Averitas Pharma, Inc.© 2021 Averitas Pharma, Inc. All rights reserved.M-QZA-US-01-21-0065 June 2021 

Best Practices for Administering Prescription Strength Capsaicin for Painful DPN of the Feet

Host: John E. Anderson, MD Guest: Raghu Mirmira, MD,PhD When treating type 1 diabetes, should we be focusing on disease prevention rather than reversal? Dr. John Anderson takes a look at prevention tactics for type 1 diabetes progression with Dr. Raghu Mirmira, a Professor of Medicine and the Director of the Translational Research Center at the University of Chicago.

Taking a New Approach to Treat Type 1 Diabetes

Guest: Kevan C. Herold, MD Guest: Chantal Mathieu, MD, PhD Experts in the immunopathology of type 1 diabetes discuss the epidemiology, non-genetic and genetic risk factors, and progression from preclinical to clinical stages of this disease. The discussion will emphasize the breakdown of immune tolerance that precedes type 1 diabetes and the subsequent pathogenetic role of islet autoantibodies responsible for its clinical manifestations. 

Type 1 Diabetes & the Role of Anti-CD3 Targeted Therapy

Host: Carol Wysham, MD Guest: Irl Hirsch, MD, MACP Why was there so much discordance between some patients’ GMI and their measured A1C? That’s the exact question Dr. Irl Hirsch from the University of Washington School of Medicine asked and explored in a paper he recently co-authored. And now Dr. Hirsch is here to share his findings.

Discovering the Discordance Between Measured A1Cs & GMIs

Host: John Buse, MD, PhD Guest: Anne Louise Peters, MD SGLT-2 inhibitors have been authorized for diabetic patients in Europe, but is it close to receiving FDA approval in the U.S.? Dr. Anne Peters of USC speaks with Dr. John Buse about SGLT-2 inhibitors and considerations for diabetic ketoacidosis, heart failure, and chronic kidney disease.

Investigating SGLT-2 Inhibitors in Diabetes: Considerations & Conversation

Host: John Buse, MD, PhD How early should we start screening for diabetes, and what tools are available to us? In recognition of Diabetes Alert Day, Dr. John Buse reviews the current screening tests and recommendations for those who are at risk of diabetes.

When & How to Screen Patients for Diabetes

Host: John E. Anderson, MD Guest: Matthias Hebrok, PhD Emerging research may offer clinicians an alternative approach to treating type 1 diabetes. Dr. John Anderson meets with Dr. Matthias Hebrok, a professor in diabetes research and director of the Diabetes Center at the University of California, San Francisco, to discuss his groundbreaking research on insulin-producing stem cells.

Exploring Stem Cell Research & Novel Options in Type 1 Diabetes

Host: John E. Anderson, MD Guest: Matthias Hebrok, PhD What are the effects of type 1 diabetes on the body? Dr. Matthias Hebrok, a professor in diabetes research and director of the Diabetes Center at the University of California, San Francisco shares some insight on type 1 diabetes and its chronic impact on patients.

Investigating Type 1 Diabetes & Its Chronic Impacts

Host: Carol Wysham, MD Guest: Alexis Markey McKee, MD Patient care has evolved amid the COVID-19 pandemic, causing unexpected challenges in managing diseases such as diabetes. Dr. Carol Wysham joins Dr. Alexis McKee, a practicing endocrinologist and an assistant professor of medicine at Washington School of Medicine in St. Louis, Missouri, to discuss how patients have been overcoming challenges in managing diabetes during the pandemic.

Managing Diabetes During the COVID-19 Pandemic

The prevalence of type 2 diabetes has increased to more than 8% of the US population, and this growth trend is expected to continue. Advances in diabetes care remain at the forefront of treatment. Diabetes Discourse features the latest developments, from new insulin therapies to exciting research and promising technology.

hubhopper

Diabetes Discourse

hubhopper